Yeleswaram Krishnaswamy

Chief Development Officer

Yeleswaram Krishnaswamy has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Aug 26, 2026.

On the most recent filing, Yeleswaram Krishnaswamy is listed as Chief Development Officer at Rapport Therapeutics, Inc. Inside the rolling window, Yeleswaram Krishnaswamy reported no open-market purchases and 10 open-market sales totaling $4.5M in RAPP. The largest disclosed transaction in the window is a sale of 37,000 RAPP shares on Aug 25, 2026, worth $1.9M.

Companies traded

Other insiders at RAPP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RAPPSale$658KAug 26SEC ↗
RAPPSale$1.9MAug 26SEC ↗
RAPPSale$20KAug 20SEC ↗
RAPPSale$809KApr 21SEC ↗
RAPPSale$17KApr 14SEC ↗
RAPPSale$321KApr 14SEC ↗
RAPPSale$358KApr 14SEC ↗
RAPPSale$13KApr 9SEC ↗
RAPPSale$303KMar 26SEC ↗
RAPPSale$85KJan 5SEC ↗
Showing 1–10 of 10
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Yeleswaram Krishnaswamy made?

Yeleswaram Krishnaswamy has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.

Which companies does Yeleswaram Krishnaswamy trade?

Yeleswaram Krishnaswamy has filed SEC Form 4 disclosures for 1 company, including RAPP.

When was Yeleswaram Krishnaswamy's most recent SEC Form 4 filing?

Yeleswaram Krishnaswamy's most recent SEC Form 4 filing on Tracefour is dated Aug 26, 2026.

What is Yeleswaram Krishnaswamy's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Yeleswaram Krishnaswamy is listed as Chief Development Officer.

What is Yeleswaram Krishnaswamy's total buy and sell value in the current window?

Inside the rolling retention window, Yeleswaram Krishnaswamy bought $0 and sold $4.5M based on SEC Form 4 filings.

What was Yeleswaram Krishnaswamy's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 37,000 RAPP shares on 2026-08-25, worth $1.9M, per SEC Form 4 filings.